Your browser doesn't support javascript.
Validation of a noninvasive aMMP-8 point-of-care diagnostic methodology in COVID-19 patients with periodontal disease.
Gupta, Shipra; Mohindra, Ritin; Singla, Mohita; Khera, Sagar; Kumar, Amit; Rathnayake, Nilminie; Sorsa, Timo; Pfützner, Andreas; Räisänen, Ismo T; Soni, Roop K; Kanta, Poonam; Jain, Akanksha; Gauba, Krishan; Goyal, Kapil; Singh, Mini P; Ghosh, Arnab; Kajal, Kamal; Mahajan, Varun; Suri, Vikas; Bhalla, Ashish.
  • Gupta S; Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Mohindra R; Department of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
  • Singla M; Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Khera S; Department of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
  • Kumar A; Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Rathnayake N; Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Sorsa T; Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Pfützner A; Department of Dental Medicine, Division of Periodontology, Karolinska Institutet, Huddinge, Sweden.
  • Räisänen IT; Clinical Research Department, Diabetes Center and Practice, Pfützner Science and Health Institute, Mainz, Germany.
  • Soni RK; Department of Oral and Maxillofacial Diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
  • Kanta P; Department of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
  • Jain A; Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Gauba K; Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Goyal K; Unit of Periodontics, Oral Health Sciences Centre, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Singh MP; Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Ghosh A; Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Kajal K; Department of Virology, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Mahajan V; Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Suri V; Department of Anaesthesia and Intensive Care, Post Graduate Institute of Medical Education and Research (PGIMER), Chandigarh, India.
  • Bhalla A; Department of Internal Medicine, Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh, India.
Clin Exp Dent Res ; 8(4): 988-1001, 2022 08.
Article in English | MEDLINE | ID: covidwho-1925901
ABSTRACT

OBJECTIVES:

The aim of this study was to validate an active matrix metalloproteinase (MMP-8) point-of-care diagnostic tool in COVID-19 patients with periodontal disease. SUBJECTS, MATERIALS, AND

METHODS:

Seventy-two COVID-19-positive and 30 COVID-19-negative subjects were enrolled in the study. Demographic data were recorded, periodontal examination carried out, and chairside tests run for evaluating the expression of active MMP-8 (aMMP-8) in the site with maximum periodontal breakdown via gingival crevicular fluid sampling as well as via a mouth rinse-based kit for general disease activity. In COVID-19-positive patients, the kits were run again once the patients turned COVID-19 negative.

RESULTS:

The overall (n = 102) sensitivity/specificity of the mouthrinse-based kits to detect periodontal disease was 79.41%/36.76% and that of site-specific kits was 64.71%/55.88% while adjusting for age, gender, and smoking status increased the sensitivity and specificity (82.35%/76.47% and 73.53%/88.24, respectively). Receiver operating characteristic (ROC) analysis for the adjusted model revealed very good area under the ROC curve 0.746-0.869 (p < .001) and 0.740-0.872 (p < .001) (the aMMP-8 mouth rinse and site-specific kits, respectively). No statistically significant difference was observed in the distribution of results of aMMP-8 mouth rinse test (p = .302) and aMMP-8 site-specific test (p = .189) once the subjects recovered from COVID-19.

CONCLUSIONS:

The findings of the present study support the aMMP-8 point-of-care testing (PoCT) kits as screening tools for periodontitis in COVID-19 patients. The overall screening accuracy can be further increased by utilizing adjunctively risk factors of periodontitis. The reported noninvasive, user-friendly, and objective PoCT diagnostic methodology may provide a way of stratifying risk groups, deciding upon referrals, and in the institution of diligent oral hygiene regimens.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Periodontal Diseases / Periodontitis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Exp Dent Res Year: 2022 Document Type: Article Affiliation country: Cre2.589

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Periodontal Diseases / Periodontitis / COVID-19 Type of study: Diagnostic study / Experimental Studies / Prognostic study / Randomized controlled trials Limits: Humans Language: English Journal: Clin Exp Dent Res Year: 2022 Document Type: Article Affiliation country: Cre2.589